Literature DB >> 1888447

Different modifying responses of capsaicin in a wide-spectrum initiation model of F344 rat.

J J Jang1, K J Cho, Y S Lee, J H Bae.   

Abstract

The modifying potential of capsaicin (CAP) on lesion development was examined in a rat multiorgan carcinogenesis model. Groups 1 and 2 were treated sequentially with diethylnitrosamine (DEN) (100 mg/kg, ip, single dose at commencement), N-methylnitrosourea (MNU) (20 mg/kg, ip, 4 doses at days 2, 5, 8, and 11), and N,N-dibutylnitrosamine (DBN) (0.05% in drinking water during weeks 3 and 4). Group 3 received vehicles without carcinogens during the initiation period. Group 4 served as the untreated control. After this initiating procedure, Groups 2 and 3 were administered a diet containing 0.01% CAP. All surviving animals were killed 20 weeks after the beginning of the experiment and the target organs examined histopathologically. The induction of GST-P+ hepatic foci in rats treated with carcinogens was significantly inhibited by treatment with CAP. CAP treatment significantly decreased the incidence of adenoma of the lung but increased the incidence of papillary or nodular (PN) hyperplasia of the urinary bladder. The tumor incidence of other organs, such as the kidney and thyroid, was not significantly different from the corresponding controls. These results demonstrated that concurrent treatment with CAP not only can inhibit carcinogenesis but can also enhance it depending on the organ. Thus, this wide-spectrum initiation model could be used to confirm organ-specific modification potential and, in addition, demonstrate different modifying effects of CAP on liver, lung, and bladder carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1888447      PMCID: PMC3049677          DOI: 10.3346/jkms.1991.6.1.31

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  4 in total

1.  Capsaicin enhances the antitumor activity of sorafenib in hepatocellular carcinoma cells and mouse xenograft tumors through increased ERK signaling.

Authors:  Su-Shan Zhang; Yu-Hao Ni; Chen-Ru Zhao; Zhen Qiao; Hong-Xia Yu; Lu-Yao Wang; Jin-Yan Sun; Chen Du; Jia-Hao Zhang; Li-Ying Dong; KeWei Wang; Jian-Jun Gao
Journal:  Acta Pharmacol Sin       Date:  2017-11-30       Impact factor: 6.150

2.  Reactive intermediates produced from the metabolism of the vanilloid ring of capsaicinoids by p450 enzymes.

Authors:  Christopher A Reilly; Fred Henion; Tim S Bugni; Manivannan Ethirajan; Chris Stockmann; Kartick C Pramanik; Sanjay K Srivastava; Garold S Yost
Journal:  Chem Res Toxicol       Date:  2012-11-06       Impact factor: 3.739

Review 3.  An updated review on molecular mechanisms underlying the anticancer effects of capsaicin.

Authors:  Seok-Cheol Cho; Hyosung Lee; Bu Young Choi
Journal:  Food Sci Biotechnol       Date:  2017-02-28       Impact factor: 2.391

Review 4.  Roles of Therapeutic Bioactive Compounds in Hepatocellular Carcinoma.

Authors:  Divya Jain; Yogesh Murti; Wasi Ullah Khan; Rajib Hossain; Mohammad Nabil Hossain; Krishn Kumar Agrawal; Rana Azeem Ashraf; Muhammad Torequl Islam; Pracheta Janmeda; Yasaman Taheri; Mohammed M Alshehri; Sevgi Durna Daştan; Balakyz Yeskaliyeva; Aliya Kipchakbayeva; Javad Sharifi-Rad; William C Cho
Journal:  Oxid Med Cell Longev       Date:  2021-10-31       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.